Connect with us

Hi, what are you looking for?

Editor's Pick

Why Aren’t More Health Policy Commentators Libertarians?

Michael F. Cannon

Cato adjunct scholar Charles Silver poses that question in the title of a guest post at John Mandrola’s and Adam Cifu’s Sensible Medicine Substack. 

The Thinker

Cifu, a professor of medicine and general internist at the University of Chicago, praises Silver’s essay:

This is the sort of essay I love. I had no idea what to expect. I wanted to object to nearly every sentence until the following sentence made me reconsider my objections. I’m still not sure my opinions have changed, but I am certainly better for having read this.

Silver writes:

Across the country, policymakers, scientists, health professionals, and advocates are calling to remove politics from vaccine policy, to promote evidence-based health policy, and to remove [RFK Jr.] as health secretary.

Yet, as far as I have been able to discover, the widespread desire to “remove politics” from health care policy has not led a single mainstream commentator to call for downsizing the government’s role.…

What I fail to understand is why mainstream commentators expect better. To me, the doctors and academics who support the ACA, Medicare For All, the public option, and other government-centric policies seem to be as ignorant of politics as Trump & Co. are of medicine.

Read the whole thing.

You May Also Like

Editor's Pick

Jennifer Huddleston and Christopher Gardner Over the past year, several heartbreaking accounts of young people who have had tragic and damaging experiences with AI...

Editor's Pick

Jeffrey A. Singer Patient Autonomy in the Age of AI Autonomous adults have always sought to conduct their own research to inform their health...

Editor's Pick

Colleen Hroncich When the first Chesterton Academy opened its doors nearly two decades ago, there was no grand plan to build a national network....

Editor's Pick

Jeffrey A. Singer On November 6, President Donald Trump announced that the government will refrain from tariffs on Eli Lilly’s and Novo Nordisk’s imported...